NCT06513767

Brief Summary

The goal of this clinical trial is to use the investigational device (Zirconia Dental Ceramics) to perform dental prosthesis in Patients with permanent teeth. The main question it aims to answer is: Is the safety and efficacy of the investigational device (Zirconia Dental Ceramics) adequate to meet the requirements for clinical use? Participants will use the investigational device (Zirconia Dental Ceramics) to perform dental prosthesis and then complete a 12-month follow-up after prostheses. During the follow-up period,participants will assess their satisfaction,while the investigator will assess the efficacy indices of prosthesis survival rate, prosthesis success rate and prosthesis quality.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

August 15, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2025

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

1.2 years

First QC Date

June 27, 2024

Last Update Submit

July 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Survival rate

    Evaluation was performed by the treatment investigator based on the actual condition of the prostheses at the time of the subject's follow-up visit (in the event that multiple prostheses are present, the most unfavourable outcome is considered), and the appropriate medical images were retained. prostheses survival was calculated after completion of the D360 visit for all subjects. In the absence of interference from external factors (e.g., severe trauma), the prostheses are considered to be survivors if they remain in situ, with or without modification, throughout the observation period.

    Day 360

Secondary Outcomes (4)

  • Survival rate

    Day 180

  • Success rate

    Day 180, Day 360

  • Prostheses quality

    Day 0, Day 180, Day 360

  • Subject satisfaction

    Day 0, Day 180, Day 360

Study Arms (1)

Investigational group

EXPERIMENTAL

Use of the investigational device (zirconia dental ceramic) to perform dental restorations

Device: Zirconia Dental Ceramics

Interventions

This investigation was conducted by enrolling subjects who met the enrolment criteria, using the investigational device (Zirconia Dental Ceramics) to perform dental prosthesess.

Investigational group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old, gender is not limited;
  • Patients with permanent teeth who were judged by the investigator to be expected to have dental prostheses using zirconia materials;
  • Subjects volunteered and signed an informed consent form.

You may not qualify if:

  • Allergy to zirconia ceramic materials or a history of extensive allergies;
  • Patients with oral mucosal ulcers;
  • Patients presents with a significant, uncontrolled, systemic disease, encompassing, but not limited to, cardiovascular disease, endocrine or metabolic disease, and immune system disease, among others;
  • Pregnant or breastfeeding, or those planning to become pregnant during the investigation period;
  • Participation in another clinical investigation within 3 months;
  • Patients with mental disorders and a lack of autonomy;
  • Meets other conditions that, in the opinion of the investigator, make participation in this clinical investigation inappropriate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Shifeng Fan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2024

First Posted

July 22, 2024

Study Start

August 15, 2024

Primary Completion

November 1, 2025

Study Completion

December 20, 2025

Last Updated

July 22, 2024

Record last verified: 2024-07